The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial

The timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) remains a matter of debate. The relationship between the timing of invasive management and left ventricular function (LVF) is largely unknown. The An Immediate or Early Invasive Strategy in Non-ST...

Full description

Bibliographic Details
Main Authors: Nick D. Fagel, Stefan G. J. Leuven, Wouter J. Kikkert, Michelle M. de Leau, Loek van Heerebeek, Robert K. Riezebos
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/16/3636
_version_ 1797523470670626816
author Nick D. Fagel
Stefan G. J. Leuven
Wouter J. Kikkert
Michelle M. de Leau
Loek van Heerebeek
Robert K. Riezebos
author_facet Nick D. Fagel
Stefan G. J. Leuven
Wouter J. Kikkert
Michelle M. de Leau
Loek van Heerebeek
Robert K. Riezebos
author_sort Nick D. Fagel
collection DOAJ
description The timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) remains a matter of debate. The relationship between the timing of invasive management and left ventricular function (LVF) is largely unknown. The An Immediate or Early Invasive Strategy in Non-ST-Elevation Acute Coronary Syndrome trial (OPTIMA-2) was a randomized controlled prospective open-label multicenter trial that randomized 249 NSTE-ACS patients to either an immediate (<3 h) invasive treatment strategy or an early strategy (12–24 h). Patients were pre-treated with a combination of aspirin, ticagrelor and fondaparinux. The aim of this prespecified sub-analysis was to assess (the recovery of) left ventricular function by analysing echocardiography data obtained <72 h after admission and at 30-day follow-up, for patients with a confirmed diagnosis of acute coronary syndrome. LVF was determined using ejection fraction (EF) and global longitudinal strain (GLS). Inter-observer variability was tested. No difference in the recovery of EF was found between an immediate and early strategy if the follow-up echocardiograms were compared to baseline: 2.5% (standard deviation (SD): 7.9) and 3.3% (SD: 8.5), <i>p</i> = 0.51, nor was there any difference in GLS recovery between the study groups: −0.8% (SD: 2.5) vs. −0.7% (SD 2.8) <i>p</i> = 0.82. If baseline and follow-up echocardiograms were compared, there was a similar but significant improvement in both EF and GLS in both separate study groups. An immediate invasive strategy in NSTE-ACS patients did not result in an improved left ventricular EF or GLS recovery compared with an early strategy.
first_indexed 2024-03-10T08:42:26Z
format Article
id doaj.art-eb44b38736b44d33b43f349c8b4abcba
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T08:42:26Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-eb44b38736b44d33b43f349c8b4abcba2023-11-22T08:11:15ZengMDPI AGJournal of Clinical Medicine2077-03832021-08-011016363610.3390/jcm10163636The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled TrialNick D. Fagel0Stefan G. J. Leuven1Wouter J. Kikkert2Michelle M. de Leau3Loek van Heerebeek4Robert K. Riezebos5Heart Center, Department of Cardiology, OLVG Hospital, 1091 AC Amsterdam, The NetherlandsHeart Center, Department of Cardiology, OLVG Hospital, 1091 AC Amsterdam, The NetherlandsHeart Center, Department of Cardiology, OLVG Hospital, 1091 AC Amsterdam, The NetherlandsHeart Center, Department of Cardiology, OLVG Hospital, 1091 AC Amsterdam, The NetherlandsHeart Center, Department of Cardiology, OLVG Hospital, 1091 AC Amsterdam, The NetherlandsHeart Center, Department of Cardiology, OLVG Hospital, 1091 AC Amsterdam, The NetherlandsThe timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) remains a matter of debate. The relationship between the timing of invasive management and left ventricular function (LVF) is largely unknown. The An Immediate or Early Invasive Strategy in Non-ST-Elevation Acute Coronary Syndrome trial (OPTIMA-2) was a randomized controlled prospective open-label multicenter trial that randomized 249 NSTE-ACS patients to either an immediate (<3 h) invasive treatment strategy or an early strategy (12–24 h). Patients were pre-treated with a combination of aspirin, ticagrelor and fondaparinux. The aim of this prespecified sub-analysis was to assess (the recovery of) left ventricular function by analysing echocardiography data obtained <72 h after admission and at 30-day follow-up, for patients with a confirmed diagnosis of acute coronary syndrome. LVF was determined using ejection fraction (EF) and global longitudinal strain (GLS). Inter-observer variability was tested. No difference in the recovery of EF was found between an immediate and early strategy if the follow-up echocardiograms were compared to baseline: 2.5% (standard deviation (SD): 7.9) and 3.3% (SD: 8.5), <i>p</i> = 0.51, nor was there any difference in GLS recovery between the study groups: −0.8% (SD: 2.5) vs. −0.7% (SD 2.8) <i>p</i> = 0.82. If baseline and follow-up echocardiograms were compared, there was a similar but significant improvement in both EF and GLS in both separate study groups. An immediate invasive strategy in NSTE-ACS patients did not result in an improved left ventricular EF or GLS recovery compared with an early strategy.https://www.mdpi.com/2077-0383/10/16/3636acute coronary syndrometimingtreatment strategyechocardiographyglobal longitudinal strain
spellingShingle Nick D. Fagel
Stefan G. J. Leuven
Wouter J. Kikkert
Michelle M. de Leau
Loek van Heerebeek
Robert K. Riezebos
The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial
Journal of Clinical Medicine
acute coronary syndrome
timing
treatment strategy
echocardiography
global longitudinal strain
title The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial
title_full The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial
title_fullStr The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial
title_full_unstemmed The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial
title_short The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial
title_sort effect of the timing of invasive management on cardiac function in patients with nste acs insights from the optima 2 randomized controlled trial
topic acute coronary syndrome
timing
treatment strategy
echocardiography
global longitudinal strain
url https://www.mdpi.com/2077-0383/10/16/3636
work_keys_str_mv AT nickdfagel theeffectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT stefangjleuven theeffectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT wouterjkikkert theeffectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT michellemdeleau theeffectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT loekvanheerebeek theeffectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT robertkriezebos theeffectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT nickdfagel effectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT stefangjleuven effectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT wouterjkikkert effectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT michellemdeleau effectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT loekvanheerebeek effectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial
AT robertkriezebos effectofthetimingofinvasivemanagementoncardiacfunctioninpatientswithnsteacsinsightsfromtheoptima2randomizedcontrolledtrial